CL2014003160A1 - Derivados de ariletinilo y sus usos en la fabricacion de medicamentos destinados al tratamiento de enfermedades relacionadas con los moduladores alostéricos del receptor mglur5. - Google Patents
Derivados de ariletinilo y sus usos en la fabricacion de medicamentos destinados al tratamiento de enfermedades relacionadas con los moduladores alostéricos del receptor mglur5.Info
- Publication number
- CL2014003160A1 CL2014003160A1 CL2014003160A CL2014003160A CL2014003160A1 CL 2014003160 A1 CL2014003160 A1 CL 2014003160A1 CL 2014003160 A CL2014003160 A CL 2014003160A CL 2014003160 A CL2014003160 A CL 2014003160A CL 2014003160 A1 CL2014003160 A1 CL 2014003160A1
- Authority
- CL
- Chile
- Prior art keywords
- ariletinyl
- medicines
- derivatives
- manufacture
- treatment
- Prior art date
Links
- 230000003281 allosteric effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12176662 | 2012-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014003160A1 true CL2014003160A1 (es) | 2015-03-13 |
Family
ID=48782352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014003160A CL2014003160A1 (es) | 2012-07-17 | 2014-11-21 | Derivados de ariletinilo y sus usos en la fabricacion de medicamentos destinados al tratamiento de enfermedades relacionadas con los moduladores alostéricos del receptor mglur5. |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US20150133505A1 (es) |
| EP (1) | EP2875000B1 (es) |
| JP (1) | JP6089104B2 (es) |
| KR (1) | KR101631041B1 (es) |
| CN (1) | CN104364233B (es) |
| AR (1) | AR091764A1 (es) |
| AU (1) | AU2013292142B2 (es) |
| BR (1) | BR112014029015A2 (es) |
| CA (1) | CA2871389C (es) |
| CL (1) | CL2014003160A1 (es) |
| CO (1) | CO7111256A2 (es) |
| CR (1) | CR20140531A (es) |
| CY (1) | CY1118205T1 (es) |
| DK (1) | DK2875000T3 (es) |
| EA (1) | EA026593B1 (es) |
| ES (1) | ES2600133T3 (es) |
| HR (1) | HRP20161691T1 (es) |
| HU (1) | HUE030177T2 (es) |
| IL (1) | IL236362A (es) |
| LT (1) | LT2875000T (es) |
| MA (1) | MA20150280A2 (es) |
| MX (1) | MX358998B (es) |
| MY (1) | MY167810A (es) |
| NZ (1) | NZ701849A (es) |
| PE (1) | PE20150184A1 (es) |
| PH (1) | PH12014502695A1 (es) |
| PL (1) | PL2875000T3 (es) |
| PT (1) | PT2875000T (es) |
| RS (1) | RS55313B1 (es) |
| SG (1) | SG11201407050UA (es) |
| SI (1) | SI2875000T1 (es) |
| TW (1) | TWI473799B (es) |
| UA (1) | UA114911C2 (es) |
| WO (1) | WO2014012851A1 (es) |
| ZA (1) | ZA201408514B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA113223C2 (xx) * | 2012-08-13 | 2016-12-26 | Арилетинілпіримідини | |
| EA026941B1 (ru) * | 2012-10-18 | 2017-06-30 | Ф. Хоффманн-Ля Рош Аг | ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ МОДУЛЯТОРОВ АКТИВНОСТИ РЕЦЕПТОРА mGluR5 |
| HRP20200638T1 (hr) | 2015-06-03 | 2020-07-10 | F. Hoffmann - La Roche Ag | Derivati etinila |
| ES2733468T3 (es) | 2015-07-15 | 2019-11-29 | Hoffmann La Roche | Derivados de etinilo como moduladores de los receptores metabotrópicos de glutamato |
| SI3484889T1 (sl) | 2016-07-18 | 2020-11-30 | F. Hoffmann-La Roche Ag | Derivati etinila |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19546462A1 (de) * | 1995-12-13 | 1997-06-19 | Bayer Ag | Diarylacetylenketone |
| PT1354875E (pt) | 2003-05-19 | 2005-03-31 | Servier Lab | Novo processo de sintese do acido (2s, 3as, 7as)-per-hidroindole-2-carboxilico e dos seus esteres e aplicacao a sintese do perindopril |
| GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
| WO2006048771A1 (en) | 2004-11-04 | 2006-05-11 | Addex Pharmaceuticals Sa | Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| GB0510139D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| NZ581817A (en) | 2007-06-03 | 2012-05-25 | Univ Vanderbilt | Benzamide mglur5 positive allosteric modulators and methods of making and using same |
| CN101544892B (zh) * | 2009-05-07 | 2012-10-03 | 石家庄诚志永华显示材料有限公司 | 一种合成二芳基乙炔类单体液晶的方法 |
| US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
| KR101554803B1 (ko) * | 2011-04-26 | 2015-09-21 | 에프. 호프만-라 로슈 아게 | Mglur5의 양성 알로스테릭 조절체로서 에틴일 유도체 |
-
2013
- 2013-07-12 WO PCT/EP2013/064747 patent/WO2014012851A1/en not_active Ceased
- 2013-07-12 NZ NZ701849A patent/NZ701849A/en not_active IP Right Cessation
- 2013-07-12 DK DK13735315.7T patent/DK2875000T3/en active
- 2013-07-12 HU HUE13735315A patent/HUE030177T2/en unknown
- 2013-07-12 MY MYPI2014003059A patent/MY167810A/en unknown
- 2013-07-12 SI SI201330415A patent/SI2875000T1/sl unknown
- 2013-07-12 PT PT137353157T patent/PT2875000T/pt unknown
- 2013-07-12 PL PL13735315T patent/PL2875000T3/pl unknown
- 2013-07-12 JP JP2015521004A patent/JP6089104B2/ja not_active Expired - Fee Related
- 2013-07-12 SG SG11201407050UA patent/SG11201407050UA/en unknown
- 2013-07-12 MA MA37795A patent/MA20150280A2/fr unknown
- 2013-07-12 LT LTEP13735315.7T patent/LT2875000T/lt unknown
- 2013-07-12 EA EA201492274A patent/EA026593B1/ru not_active IP Right Cessation
- 2013-07-12 AU AU2013292142A patent/AU2013292142B2/en not_active Ceased
- 2013-07-12 CA CA2871389A patent/CA2871389C/en not_active Expired - Fee Related
- 2013-07-12 PE PE2014002231A patent/PE20150184A1/es active IP Right Grant
- 2013-07-12 CN CN201380031736.9A patent/CN104364233B/zh active Active
- 2013-07-12 KR KR1020157001019A patent/KR101631041B1/ko not_active Expired - Fee Related
- 2013-07-12 EP EP13735315.7A patent/EP2875000B1/en active Active
- 2013-07-12 BR BR112014029015A patent/BR112014029015A2/pt not_active Application Discontinuation
- 2013-07-12 UA UAA201500231A patent/UA114911C2/uk unknown
- 2013-07-12 ES ES13735315.7T patent/ES2600133T3/es active Active
- 2013-07-12 HR HRP20161691TT patent/HRP20161691T1/hr unknown
- 2013-07-12 RS RS20160979A patent/RS55313B1/sr unknown
- 2013-07-12 MX MX2014014950A patent/MX358998B/es active IP Right Grant
- 2013-07-15 AR ARP130102507 patent/AR091764A1/es not_active Application Discontinuation
- 2013-07-16 TW TW102125419A patent/TWI473799B/zh not_active IP Right Cessation
-
2014
- 2014-10-23 CO CO14235289A patent/CO7111256A2/es unknown
- 2014-11-19 ZA ZA2014/08514A patent/ZA201408514B/en unknown
- 2014-11-20 CR CR20140531A patent/CR20140531A/es unknown
- 2014-11-21 CL CL2014003160A patent/CL2014003160A1/es unknown
- 2014-12-03 PH PH12014502695A patent/PH12014502695A1/en unknown
- 2014-12-18 IL IL236362A patent/IL236362A/en active IP Right Grant
-
2015
- 2015-01-15 US US14/597,375 patent/US20150133505A1/en not_active Abandoned
- 2015-10-26 US US14/923,308 patent/US9328090B2/en active Active
-
2016
- 2016-11-04 CY CY20161101133T patent/CY1118205T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100049I1 (hu) | Rákok kezelése PI3 kináz izoform modulátorok alkalmazásával | |
| CO6791608A2 (es) | Moduladores de la vía del complemento y usos de los mismos | |
| MX380469B (es) | Compuestos heterociclos bicíclicos y sus usos en terapia. | |
| HUE039864T2 (hu) | Gyógyászati készítmények CFTR-közvetítette betegségek kezelésére | |
| HUE057510T2 (hu) | Félplasztikus gyógyszerészeti dózisegységek elõállítása | |
| SI2760285T1 (sl) | Indazolovi inhibitorji signalne poti WNT in njihova terapevstka uporaba | |
| DK3041926T3 (da) | Indretning til in-vitro-modellering af in-vivo-væv af organer | |
| HUE037021T2 (hu) | DLL3- modulátorok és eljárások alkalmazásukra | |
| DK3234107T3 (da) | B-celler til in vivo-levering af terapeutiske midler | |
| HRP20190318T1 (hr) | Farmaceutski ili kozmetički pripravak za liječenje alopecije | |
| HUE053565T2 (hu) | Adagolási rendek Pompe betegség kezelésére | |
| CL2014002846A1 (es) | Usos terapéuticos de proteínas del factor de crecimiento del fibroblasto 21. | |
| PT3049117T (pt) | Libertação de medicamentos mediada por ultrassons | |
| PL2872497T3 (pl) | Pochodne chromanylowe do leczenia choroby mitochondrialnej | |
| HRP20180729T1 (hr) | Derivati sulfonil piperidina i njihova uporaba za liječenje bolesti posredovanih prokinetikinom | |
| PL2582366T3 (pl) | Kombinacja farmaceutyczna do leczenia bólu | |
| HRP20181623T1 (hr) | Modulatori x receptora jetre (lxr) za liječenje bolesti, poremećaja i stanja kože | |
| PT2968368T (pt) | Administração craniana de substâncias farmacêuticas | |
| HRP20181879T1 (hr) | Spojevi za liječenje pretilosti i postupci za njihovu upotrebu | |
| LT2958624T (lt) | Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas | |
| BR112016014512A2 (pt) | formulações farmacêuticas líquidas de pemetrexede | |
| PL3447070T3 (pl) | Związki do leczenia blokady mielinizacji w chorobach związanych z ekspresją białka otoczki herv-w | |
| HUE071419T2 (hu) | Gyógyászati szénhidrát készítmény terápiás alkalmazásra | |
| CO7020916A2 (es) | Utilizacion en terapeutica de derivados de imidazopiridina | |
| EP3027739A4 (en) | MODIFIED CELLS FOR THE PRODUCTION OF BLOOD CELLS |